Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
20,943
Value
$6.30M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ALNY by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,943$6.30M<0.1%+4,896+30.5%AddedHolders
Q1 202616,047$5.31M<0.1%−9,234−36.5%ReducedHolders
Q4 202525,281$10.1M<0.1%−623,063−96.1%ReducedHolders
Q3 2025648,344$295.6M0.3%+48,233+8.0%AddedHolders
Q2 2025600,111$195.7M0.2%+527,519+726.7%AddedHolders
Q1 202572,592$19.6M<0.1%+11,928+19.7%AddedHolders
Q4 202460,664$14.3M<0.1%−11,952−16.5%ReducedHolders
Q3 202472,616$20.0M<0.1%+13,161+22.1%AddedHolders
Q2 202459,455$14.4M<0.1%+3,548+6.3%AddedHolders
Q1 202455,907$8.36M<0.1%+8,890+18.9%AddedHolders
Q4 202347,017$9.00M<0.1%+1,111+2.4%AddedHolders
Q3 202345,906$8.13M<0.1%+882+2.0%AddedHolders
Q2 202345,024$8.55M<0.1%−705−1.5%ReducedHolders
Q1 202345,729$9.16M<0.1%+511+1.1%AddedHolders
Q4 202245,218$10.7M<0.1%+934+2.1%AddedHolders
Q3 202244,284$8.86M<0.1%+1,352+3.1%AddedHolders
Q2 202242,932$6.26M<0.1%−279−0.6%ReducedHolders
Q1 202243,211$7.06M<0.1%+96+0.2%AddedHolders
Q4 202143,115$7.31M<0.1%−10,478−19.6%ReducedHolders
Q3 202153,593$10.1M<0.1%00.0%UnchangedHolders
Q2 202153,593$9.09M<0.1%+100+0.2%AddedHolders
Q1 202153,493$7.55M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.